Karachi: Macter International Limited, a prominent player in the pharmaceutical industry, announced substantial growth in its sales and profit figures during its Corporate Briefing Session for the fiscal year 2025-26, held on November 13, 2026. The company attributes this success to the sustained expansion of its local portfolio, successful new product launches in low-competition and niche segments, and a marked increase in export volumes.
For the year ended June 30, 2026, Macter International reported a net turnover of Rupees 11,732 million, marking an 18% increase compared to the previous year. Excluding Afghanistan, the overall sales saw a 22% rise, with export sales experiencing a very large increase of 147%. The company's gross margin also witnessed a significant increase of 27%, attributed to a better sales mix and an increase in export business.
The profit before tax for the year stood at Rs. 1,251 million, reflecting a 10% growth over the same period last year. This improvement is largely due to increased sales, enhanced gross profit margins, and the implementation of efficiency enhancements and cost optimization measures.
According to information available from the Pakistan Stock Exchange (PSX), the company's operating expenses rose to Rs. 4,279 million, showing a big move of 21% from the previous year. Despite the increase in operating expenses, Macter International managed to achieve an operating profit of Rs. 1,381 million, which represents a 25% growth.
The finance cost for the year was recorded at Rs. 130 million, a minor move of 0.2% compared to the prior year. The profit after taxation was Rs. 698 million, demonstrating a growth of 22% over the previous fiscal year, despite an increase in current tax to Rs. 553 million, which also reflected a very large increase of 50%.
Macter International's financial performance for the fiscal year 2025-26 highlights the company's strategic efforts to expand its market presence both locally and internationally, while maintaining a focus on cost efficiency and product innovation.